NeuroOne® Medical Technologies Corporation Announces Successful Completion of Feasibility Study for Ablation ElectrodePRNewsWire • 09/23/21
NeuroOne® Medical Technologies Corporation Receives FDA 510(k) Clearance for its Evo® sEEG ElectrodePRNewsWire • 09/07/21
NeuroOne Announces Strategic Partnership with RBC Medical Innovations for Ablation ProgramPRNewsWire • 08/23/21
NeuroOne Medical Technologies' (NMTC) CEO Dave Rosa on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/14/21
NeuroOne Reports Third Quarter Fiscal 2021 Financial Results and Corporate UpdatePRNewsWire • 08/13/21
NeuroOne to Participate in Alliance Global Partners (A.G.P.) Virtual MedTech Summer Conference on July 29, 2021PRNewsWire • 07/28/21
NeuroOne to Present at Access to Giving Virtual Conference on July 15, 2021 at 2 p.m. ETPRNewsWire • 07/07/21
NeuroOne Introduces Advisory Board for Ablation Electrode Technology that Records and Ablates Brain Tissue Linked to Seizure ActivityPRNewsWire • 06/02/21
NeuroOne Announces Approval for Nasdaq Capital Market Listing; Trading Expected to Commence Tomorrow May 26th, 2021 Under the Symbol NMTCPRNewsWire • 05/25/21